Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • laura
    Senior Member
    • Sep 2008
    • 151

    Scientific Programmer - Resequencing Informatics EBI, Hinxton, Cambridge



    The Vertebrate Genomics Team and the European Genome-phenome Archive (EGA) at the European Bioinformatics Institute (EBI) seek an experienced and motivated bioinformatician to join our resequencing informatics effort, in particular to develop and deploy data analysis methods and processing pipelines for our growing collection of human disease data sets resulting from large-scale exome and whole genome sequencing projects. These data represent some of the most comprehensive ever collected for biological and disease research and their analysis requires significantly creative approaches.

    The Vertebrate Genomics Team at the EBI is an international hub of human variation data as its major projects include the 1000 Genomes data coordination centre, the European Genotype Archive, and the Ensembl project. The EBI is part of the European Molecular Biology Laboratory (EMBL) and is located on the Wellcome Trust Genome Campus at Hinxton, near Cambridge, UK.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 12:17 PM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...